Pages that link to "Q43042632"

The following pages link to Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs (Q43042632):

Displaying 13 items.

• Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management (Q35494737) (← links)
• Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice (Q35941476) (← links)
• Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. (Q36060579) (← links)
• A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms. (Q37026608) (← links)
• In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating (Q37197429) (← links)
• Review: Staphylococcus aureus and MRSA in cystic fibrosis (Q37896351) (← links)
• Implications and emerging control strategies for ventilator-associated infections. (Q38336386) (← links)
• Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model (Q38728912) (← links)
• Anti-biofilm properties of a mupirocin spray formulation against Escherichia coli wound infections. (Q40144406) (← links)
• High biofilm production by invasive multiresistant staphylococci (Q43439478) (← links)
• Isolation of strong constitutive promoters from Lactococcus lactis subsp. lactis N8. (Q53833372) (← links)
• Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection (Q82064733) (← links)
• Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus aureus Infection in an Open Fracture Animal Model (Q92505518) (← links)